Table 2.
Baseline characteristics without and with replacement fibrosis (LGE− and LGE+).
| LGE− (N = 92) | LGE+ (N = 92) | p-value | |
|---|---|---|---|
| Age (years) | 62 (10) | 62 (10) | 0.90 |
| Sex | 0.80 | ||
| Female | 17 (18%) | 16 (17%) | |
| Male | 75 (82%) | 76 (83%) | |
| Race | >0.90 | ||
| White | 47 (51%) | 47 (51%) | |
| Chinese American | 1 (1%) | 2 (2%) | |
| Black | 29 (32%) | 28 (30%) | |
| Hispanic | 15 (16%) | 15 (16%) | |
| BMI (kg/m2) | 27.9 (4.2) | 28.7 (5.1) | 0.20 |
| Systolic BP (mmHg) | 122 (18) | 127 (18) | 0.078 |
| Diastolic BP (mmHg) | 70 (10) | 72 (10) | 0.08 |
| Use of anti-hypertension Medication | 51 (55%) | 54 (59%) | 0.70 |
| Total Cholesterol (mg/dl) | 172 (33) | 179 (34) | 0.20 |
| HDL Cholesterol (mg/dl) | 49 (13) | 52 (13) | 0.20 |
| Use of lipid lowering medication | 36 (39%) | 32 (35%) | 0.50 |
| Cigarette smoking status | 0.12 | ||
| Never | 26 (28%) | 34 (37%) | |
| Former | 58 (63%) | 44 (48%) | |
| Current | 8 (9%) | 13 (14%) | |
| Diabetes | 0.50 | ||
| Normal | 59 (64%) | 49 (53%) | |
| Impaired fasting glucose | 19 (21%) | 27 (29%) | |
| Diabetes | 14 (15%) | 16 (17%) | |
| eGFR (mL/min/1.73m2) | 82 (12) | 81 (15) | 0.4 |
| Gross family income | >0.90 | ||
| $0–$19,999 | 12 (13%) | 12 (13%) | |
| $20,000–$49,999 | 30 (33%) | 32 (36%) | |
| $50,000 or more | 48 (53%) | 46 (51%) |
Figures are numbers (%) and mean (standard deviation). BMI, body mass index; BP, blood pressure; HDL, high-density lipoprotein; eGFR, estimated glomerular filtration rate; ECV, extracellular volume.